openPR Logo
Press release

Impact Of Increasing Alcohol Consumption On The Chronic Spontaneous Urticaria Market: An Emerging Driver Transforming The Chronic Spontaneous Urticaria Market Landscape

05-27-2025 05:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria

The Chronic Spontaneous Urticaria Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Chronic Spontaneous Urticaria Market?
The chronic spontaneous urticaria market is expected to grow from $2.06 billion in 2024 to $2.23 billion in 2025, at a compound annual growth rate (CAGR) of 8.6%. This growth is driven by improved diagnostic tools, increased awareness among healthcare providers, patient advocacy, and support groups, ongoing clinical trials exploring new treatments, and rising healthcare expenditures.

The chronic spontaneous urticaria market is projected to grow to $3.08 billion by 2029 at a CAGR of 8.4%. The growth is driven by an increase in CSU diagnoses, healthcare infrastructure development, favorable regulatory environments, and patient-centric care. Trends include technology innovations, advancements in biological therapies, personalized medicine, telemedicine, AI, and surging drug approvals.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16651

What Are the Different Chronic Spontaneous Urticaria Market Segments?
The chronic spontaneous urticaria market covered in this report is segmented -

1) By Treatment: Medication, Phototherapy, Other Treatments
2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
3) By Diagnosis: Physical Examination, Blood Test, Allergy Test, Other Diagnosis
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Medication: Antihistamines, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Immunosuppressants, Corticosteroids (Oral and Topical)
2) By Phototherapy: UVB Phototherapy, UVA Phototherapy, Narrowband UVB Therapy
3) By Other Treatments: Alternative Therapies, Dietary Modifications, Psychotherapy (for Stress-Related Triggers)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16651&type=smp

What Are the Primary Drivers Shaping the Chronic Spontaneous Urticaria Market?
The rising consumption of alcohol is expected to drive the chronic spontaneous urticaria market. Alcohol consumption, influenced by various social factors, can exacerbate symptoms of chronic spontaneous urticaria in some individuals. According to rehabs.UK, 55% of men and 41% of women in the UK reported weekly alcohol consumption in 2024. With increasing hospital admissions related to alcohol use, this trend is fueling the growth of the chronic spontaneous urticaria market.

Which Companies Are Leading in the Chronic Spontaneous Urticaria Market?
Major companies operating in the chronic spontaneous urticaria market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Genentech Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Celltrion Inc., Allakos Inc., United BioPharma Inc.

What Are the Latest Developing Trends in the Chronic Spontaneous Urticaria Market?
Companies in the chronic spontaneous urticaria market are advancing next-generation Briquilimab (JSP191) to improve treatment efficacy. For instance, in November 2023, Jasper Therapeutics, a US-based biotechnology firm, began Phase 1b/2a clinical trials of Briquilimab for chronic spontaneous urticaria (CSU). This monoclonal antibody targets CD47 and aims to improve quality of life for patients suffering from CSU by reducing recurrent hives and itching.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chronic-spontaneous-urticaria-global-market-report

What Are the Top Revenue-Generating Geographies in the Chronic Spontaneous Urticaria Market?
North America was the largest region in the chronic spontaneous urticaria market in 2023. The regions covered in the chronic spontaneous urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chronic Spontaneous Urticaria Market?
2. What is the CAGR expected in the Chronic Spontaneous Urticaria Market?
3. What Are the Key Innovations Transforming the Chronic Spontaneous Urticaria Industry?
4. Which Region Is Leading the Chronic Spontaneous Urticaria Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Impact Of Increasing Alcohol Consumption On The Chronic Spontaneous Urticaria Market: An Emerging Driver Transforming The Chronic Spontaneous Urticaria Market Landscape here

News-ID: 4036966 • Views:

More Releases from The Business Research Company

Commercial Foodservice Equipment Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Commercial Foodservice Equipment Industry Report 2025-2034: Market Dynamics, Tre …
The Commercial Foodservice Equipment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Commercial Foodservice Equipment Market Size During the Forecast Period? The commercial foodservice equipment market has experienced significant growth in recent years. It is projected to increase from $33.28 billion in
Emerging Trends Influencing The Growth Of The Combined Pituitary Hormone Deficiencies Market: Technological Advancements In Combined Pituitary Hormone Deficiencies Market
Emerging Trends Influencing The Growth Of The Combined Pituitary Hormone Deficie …
The Combined Pituitary Hormone Deficiencies Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Combined Pituitary Hormone Deficiencies Market Size Expected to Be by 2034? The combined pituitary hormone deficiencies market has grown steadily in recent years. It will grow from $1.95 billion
Global Coin Sorter Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Global Coin Sorter Market Outlook 2025-2034: Trends, Innovations, And Future Out …
The Coin Sorter Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Coin Sorter Market Size and Projected Growth Rate? The coin sorter market has seen steady growth in recent years. It will grow from $4.21 billion in 2024 to $4.55 billion in 2025,
Coastal And Maritime Tourism Market Anticipated To Witness Robust Growth, Surpassing $4328.28 Billion By 2029
Coastal And Maritime Tourism Market Anticipated To Witness Robust Growth, Surpas …
The Coastal And Maritime Tourism Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Coastal And Maritime Tourism Market Size and Its Estimated Growth Rate? The coastal and maritime tourism market has experienced robust growth recently. It will grow from $3010.38 billion in

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently